Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Forest Laboratories: Finding Ways to Bring Drugs to Market — Fast
- Pfizer may be big, but Forest Laboratories is nimble. The smaller company competes by ushering drugs through FDA red tape in record time. Giant: Pfizer Shadow Success: Forest Laboratories, Inc. Pfizer market cap: $96.56 billion;...
- Articles 2009-06-10
Additional Resources
- Forest Laboratories, Inc. F4Q08 (Quarter End 3/31/2008) Earnings Call Transcript
- Question-and-Answer Session Operator Your first question comes from Ian Sanderson – Cowen & Company Ian Sanderson – Cowen & Company You mentioned in the prepared remarks that the SG&A guidance contemplates pre-launch spending for milnacipran in fiscal 09 as well as launch spending. Does the revenue guidance...
- Earnings calls 2008-04-15
- Forest Laboratories Inc., F3Q09 (Qtr End 12/31/08) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions. The first question comes from the line of Gregory Gilbert with Bank of America-Merrill Lynch. Gregory Gilbert - Bank of America-Merrill Lynch First for Frankie, discuss any changes in trade inventory levels for your key products and also for clarification on that $70...
- Earnings calls 2009-01-20
- Forest Labs Q1: $170 Million Fee for DOJ; Its Numbers Are Written in "Invisible Ink"
- Forest Labs is holding a $170 million contingency fee in case it needs to settle allegations by the Department of Justice that it bribed doctors --- with such things as $1,000 gift certificates to Alain Ducasse -- into prescribing Lexapro and Celexa for children even though it was not approved...
- Blog posts 2009-04-23
- Forest Labs: Concerned About Pipeline
- Zacks.com submits: By Jason Napodano, CFA & Brian Marckx, CFA Forest Laboratories, Inc.'s FRX financial results for 2009 were inline with our expectations. EPS fell 3% on revenue growth of 2% as operating cost growth outpaced that of revenue. SG&A expenses grew 10%, reflecting increased costs related to...
- External links 2009-06-18
- Forest Laboratories Inc. F1Q10 (Qtr End 06/30/09) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions. And our first question comes from Tim Chiang with FTN Equity Capital. Tim Chiang - FTN Equity Capital I had a question about some of the guidance numbers that you provided last quarters and sort of given the strong uptake of Savella, why you're...
- Earnings calls 2009-07-21
- Forest Laboratories Inc. F2Q10 (Qtr End 30/09/09) Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Rich Silver of Barclays Capital. Rich Silver - Barclays Capital Hey Larry. Larry Olanoff Good morning. Rich Silver - Barclays Capital How are you? Larry Olanoff Good. Thank you. Rich Silver -...
- Earnings calls 2009-10-20
- << Previous
- page 1 of 1
- Next >>
